Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of the Effect of Pasireotide LAR Administration in the Lymphocele Prevention After Axillary Node Dissection for Breast Cancer

NCT01356862 is registered in ClinicalTrials.gov with Alliance Pour La Recherche en Cancerologie as lead sponsor.

NCT NCT01356862
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01356862 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of the Effect of Pasireotide LAR Administration in the Lymphocele Prevention After Axillary Node Dissection for Breast Cancer
Lead sponsor
Alliance Pour La Recherche en Cancerologie
Phase
Phase 2
Overall status
Completed
Start date
September 30, 2010
Completion date
January 31, 2013
Enrollment
91 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer